lactobacillus rhamnosus
PolandDrugs containing this active substance
-
The medicinal product is used in antibiotic-associated enteritis (including pseudomembranous colitis), in the prevention of traveler's diarrhea, and as adjuvant therapy during and after antibiotic treatment.
Form: powder for preparation of oral suspension
Active substance Dosage lactobacillus rhamnosus 100 million cells ATC: A07FA
Manufacturer: BIOMED-LUBLIN Serum and Vaccines Manufacturing Company Joint-Stock Company
-
The medicinal product is used to normalize the composition of intestinal microflora, especially after antibiotic therapy. It helps in the treatment of antibiotic-associated enteritis (including pseudomembranous colitis), prevents traveler's diarrhea, and serves as supportive treatment during and after antibiotic use.
Form: powder for preparation of oral suspension
Active substance Dosage lactobacillus rhamnosus 0.4 mld CFU ATC: A07FA
Manufacturer: Biomed-Lublin Vaccine and Serum Manufacturing Joint-Stock Company
-
The medicine helps to normalize the composition of intestinal microflora, especially after antibiotic use. It is used in antibiotic-associated enteritis (including pseudomembranous colitis), in the prevention of traveler's diarrhea, and as supportive treatment during and after antibiotic therapy.
Form: capsules, hard
Active substance Dosage lactobacillus rhamnosus 100 % l. rhamnosus pen 40 % l. rhamnosus oxy 20 % l. rhamnosus e/n 40 % ATC: A07FA
Manufacturer: Synthaverse S.A.
-
The medicine is used as support in the treatment of viral diarrhea in children, in intestinal disorders caused by a lack of proper bacterial flora, and in disorders caused by antibiotic therapy. It also helps to prevent traveler's diarrhea.
Form: powder for preparation of oral suspension
Active substance Dosage lactobacillus rhamnosus not less than 12 billion CFU ATC: A07FA
Manufacturer: BIOMED-LUBLIN Serum and Vaccines Manufacturing Company Joint-Stock Company